Champions Oncology holders re-elect 7 directors, ratify EisnerAmper, approve 2026 Equity Incentive Plan

CHAMPIONS ONCOLOGY, INC.

All seven director nominees elected at the Oct 14, 2026 annual meeting; Brian Alexander (8,241,264 for) and Scott Tobin (8,230,372) drew the least opposition.
David Sidransky received 7,154,225 for vs 1,088,685 withheld, the largest dissent; Robert Brainin got 7,904,120 for / 338,790 withheld.
EisnerAmper LLP ratified as independent auditor for fiscal year ending April 30, 2027, by 8,702,771 for to 1,845 against.
2026 Equity Incentive Plan approved 6,401,638 for / 754,480 against (~10.5% opposition) with 1,086,792 abstentions.
Say-on-pay approved 7,130,832 for vs 25,242 against; holders favored annual advisory votes (7,198,608 for 1 year), and the company will hold them yearly.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.